A multicenter study conducted by Rennes University Hospital in France has revealed promising results for the use of glucagon-like peptide-1 (GLP-1)...
A Cochrane review has found no solid evidence supporting the off-label use of ketamine for chronic pain relief. The review analyzed 67 trials invol...
ImmunityBio has initiated a Phase 2 study to evaluate the efficacy of ANKTIVA, an IL-15 agonist, in treating long COVID. The study aims to assess A...
Ultima Genomics and Gene by Gene have announced a partnership aimed at broadening access to high-quality, cost-effective DNA sequencing globally. T...
The NHS has introduced new guidelines for managing type 2 diabetes, emphasizing a personalized approach that could expand access to GLP-1 agonist t...
Chromium, a trace mineral, is being explored for its potential benefits in managing diabetes, particularly type 2 diabetes. The mineral is believed...
In the United States, the use of GLP-1 inhibitors, including medications like Ozempic, has become increasingly common, with 12% of adults having us...
Recent research conducted by Rosa Maria Bruno at Université Paris Cité indicates that Covid-19 may accelerate the aging of blood vessels, particula...
A doctor has shared insights into how severe liver diseases can affect brain health, particularly through a condition known as overt hepatic enceph...
A recent study has investigated the impact of hyperglycemia on neurodevelopmental outcomes in extremely preterm infants. Conducted as a single-cent...